Hemispherx BioPharma, Inc (NYSEAMERICAN:HEB – Get Free Report) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.00 and traded as high as $0.13. Hemispherx BioPharma shares last traded at $0.12, with a volume of 414,706 shares.
Hemispherx BioPharma Price Performance
The company has a fifty day moving average of $0.15.
About Hemispherx BioPharma
Hemispherx Biopharma, Inc, a specialty pharmaceutical company, engages in the clinical development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders in the United States. The company's products include Alferon N Injection, an injectable formulation of natural alpha interferon to treat a category of genital warts, a sexually transmitted disease; and Ampligen for the treatment of chronic fatigue syndrome (CFS).
Further Reading
- Five stocks we like better than Hemispherx BioPharma
- How to Buy Cheap Stocks Step by Step
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- Energy and Oil Stocks Explained
- The 3 Most Talked About Investments on WallStreetBets Right Now
- How to Invest in Blue Chip Stocks
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for Hemispherx BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hemispherx BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
